CartaBio
PrivateLast Round
Angel
Apr 25, 2024
Total Funding Raised
$2.8M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
CartaBio is a biotechnology company that develops diagnostic technology and an AI-driven platform to decode cellular behavior for the advancement of immune-modulating therapeutics.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI, Healthcare Analytics
Business Model
B2B
Customer Profile
Services & Consulting, Subscription SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
CartaBio Comparables
Compare CartaBio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| EvolutionaryScale | 84% | |
| Nabla Bio | 81% | |
| Cradle | 79% | |
CartaBio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Angel | Apr 25, 2024 |
CartaBio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Coho Deeptech | Angel |
| Danen Capital | Angel |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors increased 1057% MoM, from 92 to 1.1K.
- Apr 25, 2024
$3M raised from Danen Capital and Coho Deeptech.
CartaBio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about CartaBio's valuation, stock price, and market status.